Cargando…

Outcome Prediction of Hematologic Malignancy in Critically Sick People

People with hematologic malignancies (HM) frequently postulate intensive care unit (ICU) hospitalization due to organ damage caused by the disease process or treatment-related consequences. This study is aimed at looking at mortality and sign factors in adult patients with hematologic malignancy (HM...

Descripción completa

Detalles Bibliográficos
Autores principales: Velmurugan, Palanivel, Moihanavel, Vinayagam, Altayar, Malik A., Jalal, Mohammed M., Kabrah, Saeed M., Qanash, Husam, Almashjary, Majed N., Alshehri, Osama M., Kunwar, Vijay Singh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313988/
https://www.ncbi.nlm.nih.gov/pubmed/35898683
http://dx.doi.org/10.1155/2022/3234484
_version_ 1784754209834401792
author Velmurugan, Palanivel
Moihanavel, Vinayagam
Altayar, Malik A.
Jalal, Mohammed M.
Kabrah, Saeed M.
Qanash, Husam
Almashjary, Majed N.
Alshehri, Osama M.
Kunwar, Vijay Singh
author_facet Velmurugan, Palanivel
Moihanavel, Vinayagam
Altayar, Malik A.
Jalal, Mohammed M.
Kabrah, Saeed M.
Qanash, Husam
Almashjary, Majed N.
Alshehri, Osama M.
Kunwar, Vijay Singh
author_sort Velmurugan, Palanivel
collection PubMed
description People with hematologic malignancies (HM) frequently postulate intensive care unit (ICU) hospitalization due to organ damage caused by the disease process or treatment-related consequences. This study is aimed at looking at mortality and sign factors in adult patients with hematologic malignancy (HM) who have been hospitalized in the ICU. Death was one quality indicator; researchers used a machine learning approach to find determinants of death. As per the study, there have been 206 patients hospitalized in the ICU (mean age: 51.3 ± 13.6 years; 60% male). The average length of stay was three days, with 14.1% requiring extended ICU commitment. ICU death was 45.6% at 30 days, 62.6% at sixty days, and 74.3% at twelve months, rising to 59.2% at thirty days, 62.6% at sixty days, and 74.3% at twelve months. Ventilation systems and vasodilating medication were linked to higher ICU death, but admission to the ICU surgically and experiencing malignancies are linked with lower death rates. Patients with HM who are hospitalized in the ICU have a high mortality rate (45.6%), which rises to 74.3% after a year. Serious illness, postsurgical hospitalization, and malignancy were revealed as determinants of patient outcomes in multivariate analyses.
format Online
Article
Text
id pubmed-9313988
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-93139882022-07-26 Outcome Prediction of Hematologic Malignancy in Critically Sick People Velmurugan, Palanivel Moihanavel, Vinayagam Altayar, Malik A. Jalal, Mohammed M. Kabrah, Saeed M. Qanash, Husam Almashjary, Majed N. Alshehri, Osama M. Kunwar, Vijay Singh Biomed Res Int Research Article People with hematologic malignancies (HM) frequently postulate intensive care unit (ICU) hospitalization due to organ damage caused by the disease process or treatment-related consequences. This study is aimed at looking at mortality and sign factors in adult patients with hematologic malignancy (HM) who have been hospitalized in the ICU. Death was one quality indicator; researchers used a machine learning approach to find determinants of death. As per the study, there have been 206 patients hospitalized in the ICU (mean age: 51.3 ± 13.6 years; 60% male). The average length of stay was three days, with 14.1% requiring extended ICU commitment. ICU death was 45.6% at 30 days, 62.6% at sixty days, and 74.3% at twelve months, rising to 59.2% at thirty days, 62.6% at sixty days, and 74.3% at twelve months. Ventilation systems and vasodilating medication were linked to higher ICU death, but admission to the ICU surgically and experiencing malignancies are linked with lower death rates. Patients with HM who are hospitalized in the ICU have a high mortality rate (45.6%), which rises to 74.3% after a year. Serious illness, postsurgical hospitalization, and malignancy were revealed as determinants of patient outcomes in multivariate analyses. Hindawi 2022-07-18 /pmc/articles/PMC9313988/ /pubmed/35898683 http://dx.doi.org/10.1155/2022/3234484 Text en Copyright © 2022 Palanivel Velmurugan et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Velmurugan, Palanivel
Moihanavel, Vinayagam
Altayar, Malik A.
Jalal, Mohammed M.
Kabrah, Saeed M.
Qanash, Husam
Almashjary, Majed N.
Alshehri, Osama M.
Kunwar, Vijay Singh
Outcome Prediction of Hematologic Malignancy in Critically Sick People
title Outcome Prediction of Hematologic Malignancy in Critically Sick People
title_full Outcome Prediction of Hematologic Malignancy in Critically Sick People
title_fullStr Outcome Prediction of Hematologic Malignancy in Critically Sick People
title_full_unstemmed Outcome Prediction of Hematologic Malignancy in Critically Sick People
title_short Outcome Prediction of Hematologic Malignancy in Critically Sick People
title_sort outcome prediction of hematologic malignancy in critically sick people
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313988/
https://www.ncbi.nlm.nih.gov/pubmed/35898683
http://dx.doi.org/10.1155/2022/3234484
work_keys_str_mv AT velmuruganpalanivel outcomepredictionofhematologicmalignancyincriticallysickpeople
AT moihanavelvinayagam outcomepredictionofhematologicmalignancyincriticallysickpeople
AT altayarmalika outcomepredictionofhematologicmalignancyincriticallysickpeople
AT jalalmohammedm outcomepredictionofhematologicmalignancyincriticallysickpeople
AT kabrahsaeedm outcomepredictionofhematologicmalignancyincriticallysickpeople
AT qanashhusam outcomepredictionofhematologicmalignancyincriticallysickpeople
AT almashjarymajedn outcomepredictionofhematologicmalignancyincriticallysickpeople
AT alshehriosamam outcomepredictionofhematologicmalignancyincriticallysickpeople
AT kunwarvijaysingh outcomepredictionofhematologicmalignancyincriticallysickpeople